Portfolio company
Horizon Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and commercialises medicines for patients with rare, autoimmune and severe inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Eton Pharmaceuticals
This company develops and commercialises prescription medicines to treat patients living with rare diseases.
ArgenX
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
ChemoCentryx
This biopharmaceutical company develops and commercialises orally administered small molecule medicines for patients with inflammatory, autoimmune diseases and cancer.
Ultragenyx
This biopharmaceutical company develops and commercialises therapies for patients with serious rare and ultra-rare genetic diseases.
Zenas
This biopharmaceutical company develops and commercialises immunology-based therapies for patients with autoimmune diseases and rare fibroinflammatory conditions.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Coronado Biosciences
This biopharmaceutical company develops and commercialises immunotherapy agents and treatments for patients with autoimmune diseases and cancer.
Insmed Incorporated
This biopharmaceutical company develops and commercialises therapies for patients with serious and rare diseases, including chronic lung conditions and neutrophil-mediated inflammatory disorders.